What is the ROCE (Return on Capital Employed) of Cochlear this year?
The ROCE of Cochlear is 0.24 undefined this year.
Cochlear ROCE 2024
Cochlear ROCE
0.24
Ticker
COH.AX
ISIN
AU000000COH5
WKN
898321
In 2024, Cochlear's return on capital employed (ROCE) was 0.24, a 0.7% increase from the 0.23 ROCE in the previous year.
Cochlear Aktienanalyse
What does Cochlear do?
Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Cochlear's Return on Capital Employed (ROCE)
Cochlear's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Cochlear's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Cochlear's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Cochlear’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Cochlear stock
How has the ROCE (Return on Capital Employed) of Cochlear developed compared to the previous year?
The ROCE of Cochlear has increased by 0.7% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Cochlear?
A high Return on Capital Employed (ROCE) indicates that Cochlear has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Cochlear?
A low ROCE (Return on Capital Employed) can indicate that Cochlear has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Cochlear impact the company?
An increase in the ROCE of Cochlear can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Cochlear affect the company?
A decrease in ROCE of Cochlear can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Cochlear?
Some factors that can affect Cochlear's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Cochlear so important for investors?
The ROCE of Cochlear is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Cochlear take to improve the ROCE?
To improve the ROCE, Cochlear can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Cochlear pay?
Over the past 12 months, Cochlear paid a dividend of 4.06 AUD . This corresponds to a dividend yield of about 1.19 %. For the coming 12 months, Cochlear is expected to pay a dividend of 4.25 AUD.
What is the dividend yield of Cochlear?
The current dividend yield of Cochlear is 1.19 %.
When does Cochlear pay dividends?
Cochlear pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Cochlear?
Cochlear paid dividends every year for the past 27 years.
What is the dividend of Cochlear?
For the upcoming 12 months, dividends amounting to 4.25 AUD are expected. This corresponds to a dividend yield of 1.25 %.
In which sector is Cochlear located?
Cochlear is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cochlear from 4/15/2024 amounting to 2.6 AUD, you needed to have the stock in your portfolio before the ex-date on 3/21/2024.
When did Cochlear pay the last dividend?
The last dividend was paid out on 4/15/2024.
What was the dividend of Cochlear in the year 2023?
In the year 2023, Cochlear distributed 3.249 AUD as dividends.
In which currency does Cochlear pay out the dividend?
The dividends of Cochlear are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cochlear
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
